Kevin Charles Gorman, a Director at Neurocrine Biosciences Inc. (NBIX), divested 245,088 shares of the company's stock on May 19, 2026. The transactions, executed at an average price of $154.33 per share, amounted to approximately $37.82 million.
This sale by Gorman follows other notable insider transactions at Neurocrine Biosciences in recent weeks. Richard F. Pops, another executive, sold 15,000 shares for roughly $2.36 million on May 15, 2026, while Norwalk Leslie V sold 3,810 shares for approximately $590,588 on May 12, 2026.
Insider sales can be motivated by a variety of personal financial circumstances, such as portfolio diversification or tax planning, and do not inherently signal a negative view of the company's future prospects.